user

Apixaban in patients with atrial fibrillation and their risk for cardiovascular hospitalization: insights from the AVERROES trial

被引：0
|
作者：
Hohnloser, S. [1 ]
Yusuf, S. [2 ]
Eikelboom, J. [3 ]
Steg, G. [4 ]
Atar, D. [5 ]
Budaj, A. [6 ]
Halon, D. [7 ]
Lau, C. P. [8 ]
Piegas, L. S. [9 ]
Connolly, S. J. [3 ]
机构：
[1] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany
[2] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Hosp Bichat Claude Bernard, AP HP, Dept Cardiol, Paris, France
[5] Oslo Univ Hosp, Oslo, Norway
[6] Grochowski Hosp, Warsaw, Poland
[7] Lady Davis Carmel Med Ctr, Haifa, Israel
[8] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[9] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
  • [1] Apixaban in patients with atrial fibrillation and their risk for cardiovascular hospitalization: insights from the AVERROES trial
    Hohnloser, S.
    Yusuf, S.
    Eikelboom, J.
    Steg, G.
    Atar, D.
    Budaj, A.
    Halon, D.
    Lau, C. P.
    Piegas, L. S.
    Connolly, S. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 671 - 671
  • [2] The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial
    Hohnloser, Stefan H.
    Shestakovska, Olga
    Eikelboom, John
    Franzosi, Maria Grazia
    Tan, Ru San
    Zhu, Jun
    Yusuf, Salim
    Connolly, Stuart J.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (35) : 2752 - 2759
  • [3] Apixaban Versus Aspirin in Atrial Fibrillation Patients ≥ 75 Years Old: an Analysis From the AVERROES Trial
    Ng, K.
    Shestakovska, O. O.
    Eikelboom, J. W.
    Connolly, S. J.
    Yusuf, S.
    Hart, R. G.
    [J]. STROKE, 2013, 44 (12) : E187 - E187
  • [4] Clinical experience with apixaban in atrial fibrillation: implications of AVERROES
    De Caterina, Raffaele
    [J]. RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2011, 2 : 83 - 86
  • [5] Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
    Pol, Tymon
    Held, Claes
    Westerbergh, Johan
    Lindback, Johan
    Alexander, John H.
    Alings, Marco
    Erol, Cetin
    Goto, Shinya
    Halvorsen, Sigrun
    Huber, Kurt
    Hanna, Michael
    Lopes, Renato D.
    Ruzyllo, Witold
    Granger, Christopher B.
    Hijazi, Ziad
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (03):
  • [6] APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL
    Cowper, Patricia A.
    Pan, Wenqin
    Anstrom, Kevin
    Stafford, Judith
    Lopes, Renato
    Davidson-Ray, Linda
    Wallentin, Lars
    Phatak, Hemant
    Ansell, Jack
    Dorian, Paul
    Husted, Steen
    McMurray, John
    Steg, P. Gabriel
    Alexander, John
    Granger, Christopher
    Mark, Daniel
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1576 - E1576
  • [7] Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
    Cecilia Bahit, Maria
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Hohnloser, Stefan H.
    Alexander, John H.
    Lewis, Basil S.
    Aylward, Philip E.
    Verheugt, Freek W. A.
    Keltai, Matyas
    Diaz, Rafael
    Hanna, Michael
    Granger, Christopher B.
    Wallentin, Lars
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (02) : 215 - 220
  • [8] Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial
    Cecilia Bahit, Maria
    Lopes, Renato D.
    Hohnloser, Stephan H.
    Wojdyla, Daniel
    Alexander, John H.
    Lewis, Basil S.
    Aylward, Philip
    Verheugt, Freek W.
    Keltai, Matyas
    Diaz, Rafael
    Mohan, Puneet
    Granger, Christopher B.
    Wallentin, Lars
    [J]. CIRCULATION, 2012, 126 (21)
  • [9] Polypharmacy and the Impact of Apixaban on Clinical Events in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
    Focks, Jeroen Jaspers
    Brouwer, Marc A.
    Wojdyla, Daniel M.
    Tomas, Laine
    Lopes, Renato D.
    Hanna, Michael
    Lanas, Fernando
    Xavier, Denis
    Husted, Steen
    Wallentin, Lars
    Alexander, John H.
    Granger, Christopher B.
    Verheugt, Freek W.
    [J]. CIRCULATION, 2015, 132
  • [10] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
12345